For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

As expected, the FDA has moved quickly to grant emergency use authorisation (EUA) to two new-generation COVID-19 mRNA vaccines from Pfizer/BioNTech and Moderna, both targeting the new Omicron ...

Moderna's chief executive. He stressed however that the mRNA-1273.214 candidate – which combines the current SpikeVax booster with an Omicron-specific candidate – is the company's lead ...

1 booster (and Moderna’s, though the TGA has not approved this one at ... Most recently we’ve faced a soup of Omicron sub-variants, including JN.1. Since JN.1 was first detected in August 2023, this ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other high growth large cap stocks. BlackRock highlighted that its portfolio managers are broadly ...

Surprisingly, those who had taken the Moderna vaccine also reported a significantly higher level of anti-S1 than the ...

The Score is a weekly review of the biggest stock moves and the news that drove them.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.